Alternatives to Ayala Pharmaceuticals
Ayala Pharmaceuticals is a Life Sciences tool: clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers. Here are the 59 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Life Sciences companies to Ayala Pharmaceuticals
Somite.aiNot ratedAI-driven digital twin of embryo development for cell-based therapies.
Upstream BioNot ratedClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Mana.bioNot ratedAI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
QuantHealthNot ratedAI-powered patient-centric drug simulations to accelerate and de-risk drug development.
JaxBioNot ratedAI-powered blood test for early cancer detection and subtyping.
Omnix MedicalNot ratedOmnix Medical is developing a novel platform for advanced wound care management.
AummuneNot ratedDevelops a platform for individual drug customization using aptamers for cancer treatment.
EximoreNot ratedBiopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
ZipBioNot ratedCompressing biology to develop the next generation of therapies.
Gamida CellNot ratedBiotechnology company developing potentially curative cell therapies for cancer patients.
Nectin TherapeuticsNot ratedBiotech company developing next-generation immunotherapy agents to unlock the immune system.
Trobix BioNot ratedPioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.
Genocure AINot ratedGenocure AI is developing AI-powered solutions for oncology drug discovery and development.
Code OceanNot ratedCloud-based platform for reproducible computational research in life sciences.
IdentifAI GeneticsNot ratedRevolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.
Impact BiotechNot ratedDevelops and launches Padeliporfin VTP therapy for solid tumor treatment.
BioSightNot ratedClinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.
Arrakis BioNot ratedArrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.
Ella TherapeuticsNot ratedDeveloping microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
Immunyx PharmaNot ratedBiopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.
Showing the next 20 closest matches. See the rest on the Ayala Pharmaceuticals profile.
Sponsored rows are paid and labelled. Advertise on this page

